SCHEMBL28168017

SCHEMBL28168017

COc1ccc(CN(C)O[SH](=O)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ ACHE P22303 2/20 0.48
▸ BCHE P06276 1/20 0.48
▸ PYCR1 P32322 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ AOC3 Q16853 1/20 0.43
▸ IDO1 P14902 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ ALOX5 P09917 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TSPO P30536 1/20 0.41
▸ CMA1 P23946 1/20 0.41
▸ TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28168054 0.80 BCHE (0.52) ACHEBCHEMEN1KMT2AAOC3
SCHEMBL15094004 0.79 APLNR (0.59) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL14393820 0.77 APLNR (0.56) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL385286 0.74 HRH3 (0.58) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL4611890 0.74 PYCR1 (0.69) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL17099352 0.72 APLNR (0.55) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL12049800 0.72 APLNR (0.59) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL5270803 0.72 APLNR (0.59) APLNRALDH1A1HTTSMN1; SMN2ACHE
SCHEMBL10049173 0.71 AOC3 (0.66) APLNRALDH1A1HTTSMN1; SMN2PYCR1
SCHEMBL28074567 0.71 IDO1 (0.56) APLNRALDH1A1HTTSMN1; SMN2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107056799-B The double heptene sulfamide compounds of suberic acid monoanilide group oxygen bridge, its synthetic method, application and anti-breast cancer medicines composition 武汉宏兹生物技术有限公司 2019-06-14 — — CN disclosed
CN-107056799-A The double heptene sulfamide compounds of suberic acid monoanilide group oxygen bridge, its synthetic method, using and anti-breast cancer medicines composition 武汉宏兹生物技术有限公司 2017-08-18 — — CN disclosed
Send feedback